Literature DB >> 3530310

Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis.

C M Willis, E Young, D R Brandon, J D Wilkinson.   

Abstract

The histopathological features of allergic contact dermatitis were compared with those of irritant contact dermatitis in a group of 17 subjects. Each patient received simultaneous patch tests of a known allergen and a standardized irritant (benzalkonium chloride). The cellular changes occurring between 3 h and 7 days after patch test application were studied by light and electron microscopy and immunocytochemistry. No differences were observed between the induced allergic contact dermatitis (ACD) and the irritant contact dermatitis (ICD), either in the responding cell types or the sequence of cellular events. Both reactions showed a predominantly T lymphocyte infiltrate with no polymorphonuclear leukocyte involvement. Apposition of Langerhans cells to lymphocytes in the epidermis was seen in both types of response. Considerable variability in the intensity of reaction to irritant and allergen occurred within individuals. There was no statistically significant difference between the intensity of the reactions to the irritant and the allergen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530310     DOI: 10.1111/j.1365-2133.1986.tb05745.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.

Authors:  M Le; J Schalkwijk; G Siegenthaler; P C van de Kerkhof; J H Veerkamp; P G van der Valk
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

2.  Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.

Authors:  S Grabbe; M Steinert; K Mahnke; A Schwartz; T A Luger; T Schwarz
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

3.  Evolutionary changes of immunohistological characteristics of secondary lesions in pityriasis rosea.

Authors:  H Sugiura; H Miyauchi; M Uehara
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Increased anthralin irritation response in vitiliginous skin.

Authors:  W Westerhof; Y Buehre; S Pavel; J D Bos; P K Das; S R Krieg; A H Siddiqui
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses.

Authors:  S E Waltz; L Eaton; K Toney-Earley; K A Hess; B E Peace; J R Ihlendorf; M H Wang; K H Kaestner; S J Degen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

6.  Electron microscopy of epidermal and dermal Langerhans' cells in long-lasting allergy patch tests.

Authors:  L Kanerva
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Distributional changes of Langerhans cells in human skin during irritant contact dermatitis.

Authors:  A Mikulowska; B Falck
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Histopathological changes in canine allergic contact dermatitis patch test reactions. A study on spontaneously hypersensitive dogs.

Authors:  M K Thomsen; H K Thomsen
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

9.  Toll-like receptor 3 increases allergic and irritant contact dermatitis.

Authors:  Naomi Nakamura; Risa Tamagawa-Mineoka; Mayumi Ueta; Shigeru Kinoshita; Norito Katoh
Journal:  J Invest Dermatol       Date:  2014-09-17       Impact factor: 8.551

10.  Differentiating allergic and irritant contact dermatitis by high-definition optical coherence tomography: a pilot study.

Authors:  Marc A L M Boone; Gregor B E Jemec; V Del Marmol
Journal:  Arch Dermatol Res       Date:  2014-09-04       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.